A detailed history of Advisor Group Holdings, Inc. transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,193 shares of BRTX stock, worth $3,399. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,193
Previous 193 1036.27%
Holding current value
$3,399
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.32 - $1.98 $2,640 - $3,960
2,000 Added 1036.27%
2,193 $3,000
Q2 2024

Aug 13, 2024

SELL
$1.15 - $2.22 $2,301 - $4,442
-2,001 Reduced 91.2%
193 $0
Q3 2023

Nov 13, 2023

BUY
$1.45 - $4.57 $435 - $1,371
300 Added 15.84%
2,194 $3,000
Q2 2023

Aug 10, 2023

BUY
$3.49 - $6.49 $698 - $1,298
200 Added 11.81%
1,894 $8,000
Q2 2022

Aug 10, 2022

BUY
$2.95 - $5.85 $4,997 - $9,909
1,694 New
1,694 $5,000

Others Institutions Holding BRTX

About BioRestorative Therapies, Inc.


  • Ticker BRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,650,030
  • Market Cap $5.66M
  • Description
  • BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...
More about BRTX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.